Molecular Templates, Inc. (MTEMQ)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Inactive · Last trade price on Jul 21, 2025
Molecular Templates Employees
Molecular Templates had 62 employees as of December 31, 2023. The number of employees decreased by 49 or -44.14% compared to the previous year.
Employees
62
Change (1Y)
-49
Growth (1Y)
-44.14%
Revenue / Employee
$410,806
Profits / Employee
-$252,032
Market Cap
658.00
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 62 | -49 | -44.14% |
| Dec 31, 2022 | 111 | -150 | -57.47% |
| Dec 31, 2021 | 261 | 20 | 8.30% |
| Dec 31, 2020 | 241 | 73 | 43.45% |
| Dec 31, 2019 | 168 | 100 | 147.06% |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Molecular Templates News
- 8 months ago - Molecular Templates Announces Notice of Delisting and Failure to Satisfy Continued Listing Rules - GlobeNewsWire
- 9 months ago - Molecular Templates Announces Receipt of Expected Notification of Deficiency from Nasdaq Related to Delayed filing of Quarterly Report on Form 10-Q and Failure to Meet Bid Price Requirements - GlobeNewsWire
- 1 year ago - Molecular Templates, Inc. Reports Second Quarter 2024 Financial Results and Corporate Update - GlobeNewsWire
- 1 year ago - Molecular Templates, Inc. Provides Interim Update - GlobeNewsWire
- 1 year ago - Molecular Templates, Inc. Reports First Quarter 2024 Financial Results and Corporate Update - GlobeNewsWire
- 1 year ago - Molecular Templates Presents Interim Data from MT-6402 Phase I Study in Patients with PD-L1+ Solid Tumors at the 2024 American Association for Cancer Research (AACR) Annual Meeting; Monotherapy Activity in Checkpoint-Experienced Head and Neck Cancer Patie - GlobeNewsWire
- 1 year ago - Molecular Templates, Inc. Reports Fourth Quarter 2023 Financial Results and Business Update - GlobeNewsWire
- 1 year ago - Molecular Templates Announces $9.5 Million Private Placement Offering and Agreement to Amend Second Tranche of July 2023 Purchase Agreement - GlobeNewsWire